Search

everythinglearnresearchcommunity

for

Search:↓

New treatments like biologics and JAK inhibitors show promise for severe scalp inflammation when traditional methods fail.

Trichotillomania treatment is improving with behavior therapy and new drug approaches, but challenges like stigma and underdiagnosis remain.

Chemotherapy often causes skin and hair issues, but early management can help improve patient care.

Deleting NIPP1 in mouse skin cells causes early aging and chronic skin issues.

The conclusion is that future trials should report specific details about the PRP composition to better understand its effects on urologic conditions.

A protein called EGFR protects hair follicle stem cells, and when it's disrupted, hair follicles can be damaged, but blocking certain pathways can restore hair growth.

The Wnt/β-catenin signaling pathway is important for skin wound healing and affects inflammation, cell growth, and other healing processes.

The article concludes that understanding Frontal Fibrosing Alopecia (FFA) is crucial for effective treatment, which includes medication like 5α-reductase inhibitors and hydroxychloroquine.

Low-dose sorafenib can cause severe facial acne, treatable with topical medication.

Early diagnosis and treatment of frontal fibrosing alopecia are crucial to prevent permanent hair loss.

Hidradenitis Suppurativa is likely an autoinflammatory disease, and better understanding its causes could improve treatments.

New treatments for common hair loss might be safer and more effective than current options.

Some blood-thinning medications can increase the risk of bleeding, and certain factors like genetics and other health conditions affect their safety and effectiveness.

HA-P5 effectively treats acne without causing side effects seen in other treatments.

Research on hair disorders has advanced, with promising future progress in understanding and treating these conditions.

Dutasteride injections can help hair growth in androgenic alopecia but need more research for long-term use.

Hair loss can be treated with common methods like minoxidil and finasteride, but new potential treatments include growth factors, cytokines, and platelet-rich plasma injections.

A patient's grey hair regained color during treatment with adalimumab.

The article suggests that targeting specific immune pathways could help control and treat the skin disease hidradenitis suppurativa.

Facial hidradenitis suppurativa can be mistaken for acne but requires different treatment.

EGFR inhibitors for lung cancer can cause severe skin issues.

New cancer treatments are less harmful to hair but can still cause hair loss, color, shape, and growth changes.

Reducing gefitinib dosage improved hair loss, but scarring remained.

Blocking EGFR can cause skin inflammation by disrupting IL-1 signaling.

Skin side effects from cancer treatments can lead to changes in therapy and are common, with nail changes being the most frequent.

Some drugs, especially biologics, can cause skin reactions that look like other skin diseases, and stopping the drug usually helps clear up these reactions.

Erlotinib can cause scalp pustules and hair loss, needing early treatment with antibiotics and steroids.

Cancer treatment drugs can cause permanent hair loss by damaging hair follicle stem cells, but a specific inhibitor might reverse this effect.

PRIDE syndrome helps identify skin side effects from EGFR inhibitors like erlotinib.

EGFR inhibitors cause skin issues and hair loss by weakening skin defenses, suggesting antibiotics and targeted treatments can help.